Pringle Kirsty G, Wang Yu, Lumbers Eugenie R
Mothers and Babies Research Centre, Hunter Medical Research Institute, John Hunter Hospital & School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, New South Wales, Australia
Mothers and Babies Research Centre, Hunter Medical Research Institute, John Hunter Hospital & School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, New South Wales, Australia.
Physiol Rep. 2015 Apr;3(4). doi: 10.14814/phy2.12313.
Very high concentrations of prorenin protein occur in human amniotic fluid and amnion. The source of amniotic fluid prorenin is likely the decidua, as it has the highest levels of prorenin mRNA (REN). Conversely, REN mRNA levels in amnion and chorion are very low. This study aimed to investigate whether decidual prorenin could cross the amnion and accumulate in amniotic fluid. Late gestation amnion was incubated for 24 h in the presence or absence of recombinant human (rh)prorenin. REN mRNA abundance was determined by qPCR and prorenin protein levels in the supernatant and tissue were measured by an ELISA. Prior to incubation only 3/11 amnion samples had REN mRNA but measurable levels of prorenin protein were found (1.4 ng/mg total protein). After 24 h incubation, REN mRNA was found in all explants and levels were significantly increased (P = 0.03) but prorenin protein levels in amnion were unchanged. Prorenin protein levels in the supernatant were, however, increased (P = 0.048). Incubation with (rh)prorenin significantly increased amnion tissue prorenin levels (2.8 ng/mg total protein, P = 0.001); REN mRNA levels were unchanged. Therefore, amnion explants express small amounts of REN and secrete prorenin protein. Prorenin is also taken up by amnion. We postulate that the amniotic renin angiotensin system (RAS) alters pregnancy outcome through effects on gestation length and amniotic fluid volume. Since human amnion can take up and secrete prorenin protein, the activity of both amnion and amniotic fluid RASs can be amplified by prorenin produced by other intrauterine tissues.
人羊水和羊膜中存在非常高浓度的肾素原蛋白。羊水肾素原的来源可能是蜕膜,因为它具有最高水平的肾素原信使核糖核酸(REN)。相反,羊膜和绒毛膜中的REN信使核糖核酸水平非常低。本研究旨在调查蜕膜肾素原是否能穿过羊膜并在羊水中积聚。将妊娠晚期羊膜在有或无重组人(rh)肾素原的情况下孵育24小时。通过定量聚合酶链反应(qPCR)测定REN信使核糖核酸丰度,并通过酶联免疫吸附测定(ELISA)测量上清液和组织中的肾素原蛋白水平。孵育前,仅3/11的羊膜样本有REN信使核糖核酸,但发现有可测量水平的肾素原蛋白(1.4纳克/毫克总蛋白)。孵育24小时后,在所有外植体中均发现REN信使核糖核酸,且水平显著升高(P = 0.03),但羊膜中的肾素原蛋白水平未改变。然而,上清液中的肾素原蛋白水平升高了(P = 0.048)。用(rh)肾素原孵育显著增加了羊膜组织肾素原水平(2.8纳克/毫克总蛋白,P = 0.001);REN信使核糖核酸水平未改变。因此,羊膜外植体表达少量的REN并分泌肾素原蛋白。肾素原也被羊膜摄取。我们推测羊膜肾素-血管紧张素系统(RAS)通过对妊娠时长和羊水量的影响来改变妊娠结局。由于人羊膜可以摄取和分泌肾素原蛋白,羊膜和羊水RAS的活性可被其他子宫内组织产生的肾素原放大。